ThursdayFeb 09, 2023 10:30 am

Nemaura Medical, Inc. (NASDAQ: NMRD) Featured in Coverage of The MicroCap Rodeo’s 3rd Annual Winter Wonderful and Best Ideas Investor Conference

Nemaura Medical (NASDAQ: NMRD) is a medical technology company developing and commercializing non-invasive wearable diagnostic devices. The company is currently commercializing sugarBEAT(R) and proBEAT(TM). sugarBEAT(R), a CE mark approved Class IIb medical device, is a non-invasive and flexible continuous glucose monitor (“CGM”) providing actionable insights derived from real time glucose measurements and daily glucose trend data, which may help people with diabetes and pre-diabetes to better manage, reverse, and prevent the onset of diabetes. Nemaura has submitted a PMA (Premarket Approval Application) for sugarBEAT(R) to the U.S. FDA. proBEAT(TM) combines non-invasive glucose data processed using artificial intelligence and a digital healthcare…

Continue Reading

WednesdayFeb 08, 2023 12:13 pm

Food Allergies Worsen Cost of Living for Impacted Individuals

An estimated 32 million Americans, including 26 million adults and 5.6 million minors, live with a food allergy. For many of these Americans, their day-to-day lives involve avoiding certain foods that can trigger moderate to severe allergic reactions. However, subsisting on such a restricted diet can be pretty costly, especially if affected persons are allergic to a range of foods. As the cost of living increases amid global supply chain issues and inflation, people with food allergies are experiencing even higher living costs than those without allergies. Data collected by the Allergy Team has revealed that families living on restricted…

Continue Reading

WednesdayFeb 08, 2023 9:45 am

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Encouraged by Nanosized Antibody Study Results as Market Forecasts Predict Rapid Growth

Market analysts predict monoclonal antibodies (“mAbs”) will be the fastest-growing revenue segment of the biologics medicinal market through the end of the decade BiondVax Pharmaceuticals is focused on developing and commercializing novel mAb “biobetter” NanoAbs to meet underserved medical needs addressing large market disorders The company’s recent work with an inhaled nanosized antibody for COVID has shown exceptionally promising results, virtually preventing illness and eliminating the SARS-COV-2 virus in a hamster population With COVID as first target, the company’s pipeline aims to provide effective medical responses to other disorders such asthma, psoriasis, psoriatic arthritis, and macular degeneration Immunotherapeutic product innovator…

Continue Reading

TuesdayFeb 07, 2023 12:24 pm

New Model Sheds Light on Patterns of Infectious Illnesses

The COVID-19 pandemic was a major reminder of just how problematic infectious diseases can be, especially if we aren’t intimately aware of their spread patterns. Only a few months after the disease was discovered in Wuhan, China, significant chunks of the world were shut down to avoid mass infections that would place undue strain on their medical systems. Even though we are now out of the eye of the storm, it is important that we understand how such infectious diseases behave to prevent future pandemics. Fortunately, a new modeling approach capable of accounting for contact patterns between different age groups…

Continue Reading

MondayFeb 06, 2023 11:15 am

MetAlert, Inc. (MLRT) – Developing New and Practical GPS Tracking and Other Health Tech Solutions for Real-World Caregivers and Businesses

MetAlert, a developer of personal protective medical equipment and supplies, owes much of its growth to acting on feedback from real-world caregivers who use its products for the monitoring and tracking of vulnerable patients This connection with caregivers has yielded advanced products such as the award-winning, multi-patented GPS SmartSole, Invisabelt, Take-Along Tracker, and Rover Tracker, among others Attention to consumers has also led to its line of hearing aids, such as its flagship Hear IQ 4 rechargeable, app-controlled hearing aid, and its RoomMate wall-mounted 3D sensors for looking after patients without intruding on their personal space MetAlert (OTC: MLRT), a…

Continue Reading

MondayFeb 06, 2023 10:53 am

Study Finds Boosting White Blood Cell Counts May Improve Treatment Outcomes

Glioblastoma is an aggressive type of brain and spinal cord cancer that typically affects brain tissues, usually the frontal and temporal lobes of the brain. Treatment options for the debilitating brain cancer tend to lower white blood cell counts for six months to a year, which inadvertently impacts patient survival rates. Scientists and researchers have tried to determine the specific cause of this extended drop in white blood cell levels and its impact on survivability for years with little success. New research from the St. Louis Washington University School of Medicine has now revealed one probable reason for the lower…

Continue Reading

MondayFeb 06, 2023 10:30 am

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Aiming to Capture Significant Market Share for Treatment and Prevention of COVID-19 Illness with Innovative Inhaled NanoAb

BiondVax is a biotechnology company focused on developing, manufacturing, and commercializing innovative immunotherapeutic products The company is developing nanosized antibodies (“NanoAbs”) addressing large market diseases underserved by current treatments, with its lead candidate targeting COVID-19 The FDA recently revoked the sole authorization of a COVID prophylactic, Evusheld, citing the inability of the monoclonal antibody cocktail to neutralize emerging subvariants of the Omicron variant BiondVax’s lead NanoAb candidate shows superior advantages to monoclonal antibodies, with the data gathered strengthening the value proposition of the COVID-19 NanoAb as a safe, efficacious, and convenient therapeutic and prophylactic drug The Food and Drug Administration…

Continue Reading

FridayFeb 03, 2023 10:53 am

Global Clinical Guidelines to Prevent, Manage Cardiac Complications Among Pediatric Cancer Patients Published

Researchers from the Murdoch Children’s Research Institute in Melbourne have recently published the first-ever clinical guidelines to help prevent and address cardiac complications in pediatric cancer patients who are currently undergoing treatment.  A growing body of research has revealed in recent years that pediatric cancer patients face a significant risk of developing additional medical complications later in life. Some of the treatments used to address tumors, such as radiation therapy, can be quite damaging to healthy cells. Even grown adults suffer side effects such as anemia, appetite loss, fatigue, bruising, bleeding, and hair loss.  For children, these treatments can disrupt…

Continue Reading

ThursdayFeb 02, 2023 12:21 pm

How Emotional Support, Service Dogs Differ

Although emotional support and service dogs may seem similar to the uninformed viewer, there are several critical differences between these two types of dogs. Dogs have been man's best friend for thousands of years, sticking with humans since the early days of cave painting and stone tools, through the middle ages, the industrial revolution and into the modern age. Dogs helped to protect human settlements from dangerous animals and other people; they  were also instrumental in guarding and herding livestock for thousands of years. While plenty of dogs around the world still serve this function, most people use dogs for…

Continue Reading

ThursdayFeb 02, 2023 9:00 am

MetAlert, Inc. (MLRT) Patient Tracking Technology To Gain User Access in Sweden’s Cognitive Care Centers

GPS-enabled location device developer MetAlert provides geographical tracking technology that is discrete and functional through shoe inserts that provide data connectivity to cognitive patient caregivers MetAlert announced in January that it is expanding the reach of its SmartSole flagship product through an agreement with Sweden’s government that was established by distribution partner Posifon AB Government agencies across Europe and in the United States have recognized the importance of being able to monitor the whereabouts of patients with cognitive concerns MetAlert’s development team has improved the SmartSole with a battery capable of lasting up to five days, and the company plans…

Continue Reading

Official NewsWire Relationships

BIO Informa DGE Dynamic Global Events DTC Healthcare Conference Kiasco Reasearch Nexus Conferences Octane

BioMedWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 415.949.5050